Residual pharmaceutically active compounds (PhACs) in aquatic environment - status, toxicity and kinetics: a review

Awareness of residual pharmaceutically active compounds (PhACs) in aquatic ecosystems is growing as research into these pollutants increases and analytical detection techniques improve. For most pharmaceuticals analyzed, the effects on aquatic organisms have usually been investigated by toxic assays...

Full description

Saved in:
Bibliographic Details
Published in:Veterinární medicína 2009-01, Vol.54 (7), p.295-314
Main Authors: Li, Z.H., Randak, T.
Format: Article
Language:English
Subjects:
Aquatic ecosystems
Aquatic environment
Aquatic organisms
Environmental effects
Environmental testing
kinetics
Mathematical analysis
Organisms
Pharmaceuticals
Pharmacokinetics
Pharmacology
Pollutants
Pollution detection
residual phacs
status
Toxicity
Wastewater
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Awareness of residual pharmaceutically active compounds (PhACs) in aquatic ecosystems is growing as research into these pollutants increases and analytical detection techniques improve. For most pharmaceuticals analyzed, the effects on aquatic organisms have usually been investigated by toxic assays in the laboratory. However, little is known about integral analysis of pharmacokinetics in aquatic organisms and specific relations between pharmacokinetic parameters and influence factors. Moreover, the influence of the organisms involved and numerous other external factors complicates development of standard tests for environmental evaluation. Current knowledge about residual pharmaceuticals in the aquatic environment, including status, toxic effects, and pharmacokinetics in aquatic organisms, are reviewed. Based on the above, we identify major gaps in the current knowledge and some directions for future research, such as improvement of techniques to remove residual pharmaceuticals from wastewater, and the establishment of standard pharmaceutical modes of action.
ISSN:0375-8427
1805-9392
DOI:10.17221/97/2009-VETMED